No statistically significant differences were observed between the two arms with regard to 6-month survival rates ( 40 % vs. 49 % ) , median overall survival ( 5.5 vs. 6.3 months ) , median progression-free survival ( 1.9 vs. 3.0 months ) , and overall response rate ( 4.7 % vs. 8.3 % ) .